Technology: Cancer
Industry: End-to-end Drug Development, Investor
Headquarters: Boston, Massachusetts, United States
Zip: NA
Founded Date: 2013-01-01
Employees Number: 51-100
Funding Status: M&A
Acquisitions Number: Made Acquisitions, Was Acquired
Investors Number: 8
Total Funding: 455000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-11-27
Last Funding Type: Series C

Visit Website
Register and Claim Ownership